Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576875 · ClinicalTrials.gov registry record
Duke Conte Center for the Neuroscience of Depression in Late Life
A clinical trial of Major Depression, sponsored by Duke University.
- Completed
- Registry status
- 795
- Enrollment target
- 1
- Study location
NCT00576875 is a study of Major Depression that has completed, run by Duke University. The registered enrollment target is 795 participants, above the 299-participant average among 28 other Major Depression trials with a reported enrollment target (166% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00576875, a study of Major Depression, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 795 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed Silvio O. Conte Center for Neuroscience of Depression will focus on understanding the neurobiological mechanism of depression. A total of 5 projects are proposed. The center is focused on a single hypothesis. The first project examines localization of lesions, structural changes in critical regions subserving the circuit, alterations in the white matter tracts relevant to the circuit and changes in glutamate. The second project uses post mortem cell counting and cellular localization in serotonin receptors and assessment of the type of cell loss in the orbitofrontal cortex. The third project uses cognitive paradigms and functional MRI to probe the circuit and the role of brain lesions and serotonin on the functioning of this circuit. The fourth project uses transgenic and knockout mice to examine to role of norepinephrine and serotonin as it relates to the circuit. The final project is designed to assess in these transgenic mice using multielectrode array of single neuron recordings of the firing pattern of the circuit neurons in various states and tasks and the role of monoamines in modulating this circuit.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 795 participants |
| Start Date | 2006-08 |
| Est. Completion | 2011-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576875
The ClinicalTrials.gov registry entry for NCT00576875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 795 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 299-participant average among 28 other Major Depression trials with a reported enrollment target (166% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depression appearing as the primary indexed condition, and to 0 interventions.
NCT00576875 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00576875 about?
NCT00576875 is a clinical study titled "Duke Conte Center for the Neuroscience of Depression in Late Life". The proposed Silvio O. Conte Center for Neuroscience of Depression will focus on understanding the neurobiological mechanism of depression. A total of 5 projects are proposed. The center is focused on a single hypothesis. The first project examines localization of lesions, structural changes in crit...
What is the current status of trial NCT00576875?
This trial is currently completed. The enrollment target is 795 participants. The study started on 2006-08. Estimated completion is 2011-07.
What conditions does trial NCT00576875 study?
This clinical trial studies the following conditions: Major Depression.
Who is sponsoring clinical trial NCT00576875?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00576875 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
RECRUITING · Phase 1
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
RECRUITING
-
Leucine in Midlife Depression
RECRUITING · Phase 2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.